EGFR and lung carcinoma: Through literature review, we found two DRCEs NOP14‐AS1_hsa‐miR‐335_EGFR and NOP14‐AS1_hsa‐miR‐335_SREBF1 were associated with lung cancer drug responses (Fig. 4B).